AAAAAA

   
Results: 1-8 |
Results: 8
High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize
Authors: Junghanss, C Leithauser, M Wilhelm, S Kleine, HD Knopp, A Decker, S Alscher, A Casper, J Kohne, CH Freund, M
Citation: C. Junghanss et al., High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize, ANN HEMATOL, 80(2), 2001, pp. 96-102
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
Authors: Rick, O Bokemeyer, C Beyer, J Hartmann, JT Schwella, N Kingreen, D Neureither, S Metzner, B Casper, J Wandt, H Hartmann, F Schmoll, HJ Derigs, G Gerl, A Berdel, WE Kanz, L Siegert, W
Citation: O. Rick et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer, J CL ONCOL, 19(1), 2001, pp. 81-88
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
Authors: Scheulen, ME Hilger, RA Oberhoff, C Casper, J F'reund, M Josten, KM Bornhauser, M Ehninger, G Berdel, WE Baumgart, J Harstrick, A Bojko, P Wolf, HH Schindler, AE Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
Authors: Porter, DL Collins, RH Hardy, C Kernan, NA Drobyski, WR Giralt, S Flowers, MED Casper, J Leahey, A Parker, P Mick, R Bate-Boyle, B King, R Antin, JH
Citation: Dl. Porter et al., Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions, BLOOD, 95(4), 2000, pp. 1214-1221
Immunotherapy in pediatric oncology - Into the twenty-first century
Authors: Orentas, R Casper, J
Citation: R. Orentas et J. Casper, Immunotherapy in pediatric oncology - Into the twenty-first century, IMMUNOL ALL, 19(2), 1999, pp. 309
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer
Authors: Bokemeyer, C Gerl, A Schoffski, P Harstrick, A Niederle, N Beyer, J Casper, J Schmoll, HJ Kanz, L
Citation: C. Bokemeyer et al., Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer, J CL ONCOL, 17(2), 1999, pp. 512-516
Treatment of patients with cisplatin-refractory testicular germ-cell cancer
Authors: Bokemeyer, C Kollmannsberger, C Harstrick, A Beyer, J Gerl, A Casper, J Metzner, B Hartmann, JT Schmoll, HJ Kanz, L
Citation: C. Bokemeyer et al., Treatment of patients with cisplatin-refractory testicular germ-cell cancer, INT J CANC, 83(6), 1999, pp. 848-851
The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors
Authors: Bokemeyer, C Harstrick, A Beyer, J Metzner, B Ruther, U Hartmann, JT Holstein, K Derig, HG De Wit, R Casper, J Schoffski, P Kuhrer, I Illiger, HJ Kempf, B Reichle, A Foller, A Hossfeld, DK Fischer, JT Berdel, WE Gerhartz, HH Kirchner, H Pfluger, KH Ostermann, H Kanz, L Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323
Risultati: 1-8 |